Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males

Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males

Abstract Insulin aspart (IAsp) is one of the main therapies used to control blood glucose after a meal. This study aimed to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of 2 rapid-acting IAsp products: a new IAsp biosimilar (RD10046) and NovoRapid. In a single-center, randomized, sing...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Liu, Hongling Yu, Lisi Sun, Jingtao Qiao, Sainan Wai, Shuang Li, Jiaqi Li, Huiwen Tan, Yerong Yu
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/b9a0825201e5476e81ccc868c6a633d2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items